MetaCure Implant For Type 2 Diabetes: Overseas Trials To Wrap Up By 2012
This article was originally published in The Pink Sheet Daily
Executive Summary
While the current plan for the U.S. market is focused on an eventual PMA submission for type 2 diabetes, the firm may also pursue an obesity indication.